Da-liu Min

Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Pterostilbene suppresses human endometrial cancer cells in vitro by down-regulating miR-663b.

Pterostilbene suppresses human endometrial cancer cells in vitro by down-regulating miR-663b.

Journal: Acta pharmacologica Sinica
Published: September 25, 2016

Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301.

Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301.

Journal: OncoTargets and therapy
Published: June 17, 2016

Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells.

Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells.

Journal: BMC cancer
Published: September 11, 2015

Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.

Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.

Journal: Acta pharmacologica Sinica
Published: August 25, 2015

Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study.

Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study.

Journal: Asian Pacific journal of cancer prevention : APJCP
Published: April 01, 2015

p21-activated kinase 7 is an oncogene in human osteosarcoma.

p21-activated kinase 7 is an oncogene in human osteosarcoma.

Journal: Cell biology international
Published: October 15, 2013

KLF8 knockdown suppresses proliferation and invasion in human osteosarcoma cells.

KLF8 knockdown suppresses proliferation and invasion in human osteosarcoma cells.

Journal: Molecular medicine reports
Published: June 30, 2013

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis.

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis.

Journal: PloS one
Published: January 15, 2013

Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Journal: Asian Pacific journal of cancer prevention : APJCP
Published: December 19, 2012

Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Journal: Current medical research and opinion
Published: December 11, 2012

Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis.

Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis.

Journal: International journal of cancer
Published: August 13, 2012

Overall survival benefits for combining targeted therapy as second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of published data.

Overall survival benefits for combining targeted therapy as second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of published data.

Journal: PloS one
Published: August 06, 2012
Showing 1-12 of 16

Last Updated: 09/26/2026